HER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancer: Updates and Insights
Update: 2025-10-29
Description
Are you ready for the evolving treatment paradigm in HER2-positive gastroesophageal adenocarcinoma (GEA) and biliary tract cancer (BTC)?
Credit available for this activity expires: 10/24/27
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/her2-positive-gastroesophageal-adenocarcinoma-and-biliary-2025a1000sr3?&ecd=bdc_podcast_libsyn_mscpedu
Comments
In Channel



